Showing results (61-70 of 196) with videos related to
Sort By:
Pageof 20
Life Sciences|March 30, 1987
Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonistsP S Portoghese, A W Lipkowski, A E TakemoriJournal of Medicinal Chemistry|July 1, 1986
Peptides as receptor selectivity modulators of opiate pharmacophoresA W Lipkowski, S W Tam, P S PortogheseJournal of Medicinal Chemistry|June 1, 1987
Nonequilibrium opioid antagonist activity of 6,14-dideoxynaltrexone derivativesJ W Schoenecker, A E Takemori, P S PortogheseJournal of Medicinal Chemistry|May 1, 1987
Opioid agonist and antagonist activities of monofunctional nitrogen mustard analogues of beta-chlornaltrexamineJ W Schoenecker, A E Takemori, P S PortogheseLife Sciences|January 1, 1993
Spinal delta 2 but not delta 1 opioid receptors are involved in intracerebroventricular beta-endorphin-induced antinociception in the mouseL F Tseng, K A Collins, P S PortogheseJournal of Medicinal Chemistry|May 1, 1986
Crystal structures of alpha- and beta-funaltrexamine: conformational requirement of the fumaramate moiety in the irreversible blockage of mu opioid receptorsJ F Griffin, D L Larson, P S PortogheseJournal of Medicinal Chemistry|July 1, 1991
Persistent binding of fatty acyl derivatives of naltrexamine to opioid receptorsP S Portoghese, A Garzon-Aburbeh, D L LarsonOrganic Letters|February 7, 2001
Investigation of phenolic bioisosterism in opiates: 3-sulfonamido analogues of naltrexone and oxymorphoneC R McCurdy, R M Jones, P S PortogheseJournal of Medicinal Chemistry|August 6, 1993
Synthesis and kappa-opioid antagonist selectivity of a norbinaltorphimine congener. Identification of the address moiety required for kappa-antagonist activityC E Lin, A E Takemori, P S PortogheseEuropean Journal of Pharmacology|April 9, 1981
The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexoneA E Takemori, D L Larson, P S PortoghesePageof 20